The effect of Artemisia herbal cream product on improving the symptoms of patients with psoriasis
Phase 2
Recruiting
- Conditions
- Condition 1: Psoriasis. Condition 2: Other psoriasis. Condition 3: Moderate to severe psoriasis.Generalized pustular psoriasisL40.0Psoriasis vulgarisOther psoriasisL40.8L40.1
- Registration Number
- IRCT20080901001157N20
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with psoriasis.
15 to 50 years old who are able to use the topical product.
Personal desire to participate in the project and the signing of a written consent.
Exclusion Criteria
People who are allergic to plant extracts and Artemisia annua plant extract.
pregnant women.
Lactating women.
Patients treated for systemic psoriasis 3 months before and during the study.
Patients who have a history of malignant disease, taking anti inflammatory and immunosuppressive drugs.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Artemisia herbal cream's efficacy in psoriasis vulgaris (L40.0) treatment?
How does Artemisia herbal cream compare to IL-23 inhibitors in managing moderate to severe psoriasis?
Which biomarkers correlate with response to Artemisia herbal cream in IRCT20080901001157N20 psoriasis trials?
What adverse events are associated with Artemisia herbal cream in phase II psoriasis studies?
Are there synergistic effects combining Artemisia herbal cream with topical corticosteroids for generalized pustular psoriasis?